Research Capabilities


Synairgen has specialised scientific research and clinical teams dedicated to drug discovery and development in asthma, COPD and other respiratory diseases. Their main activities are summarised opposite:


  • Advanced human in vitro models generated from the BioBank samples, including use of virus infection models (experienced in use of rhinovirus, RSV, influenza etc.)
  • Lung biomarker validation and assessment
  • Application of human tissue models for:
    • Target discovery
    • Target validity
    • Support clinical activity


  • Extensive BioBank of relevant tissue, cells, blood and airway secretions from volunteers (both diseased and healthy)
  • Phase I &II trial capability in respiratory patients during naturally acquired cold infections

For more detailed information please go to Technology and Programmes